دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Body fat patterning in lean Asian Indians with diabetes: Case-control study
Rohan Goel a, 1 , Bhanu Malhotra b, 1 , Ashu Rastogi b, *, Tulika Singh c , Anil Bhansali b , Sanjay Bhadada
doi : 10.1016/j.dsx.2023.102728
Volume 17, Issue 3, March 2023, 102728
Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes
Jothydev Kesavadev a, *, Gopika Beena Chandran a , Anjana Basanth a , Gopika Krishnan a , Arun Shankar a , Sunitha Jothydev a
doi : 10.1016/j.dsx.2023.102731
Volume 17, Issue 3, March 2023, 102731
Protein intake and postprandial hyperglycemia in children and adolescents with type 1 diabetes mellitus, a pilot study
Dalia Dalle a, *, Sarine Shahmirian b , Jennifer Dorman c , MaryAnn O'Riordan b , Teresa N. Zimmerman b, c , Jamie R. Wood
doi : 10.1016/j.dsx.2023.102739
Volume 17, Issue 3, March 2023, 102739
To describe the change in glucose and the resulting postprandial hyperglycemia (PPH) that occurs after dietary protein intake (PI) in children with type 1 diabetes (T1D).
Barriers and facilitators in dietary and physical activity management of type 2 diabetes: Perspective of healthcare providers and patients
Divya Tripathi a , Naval K. Vikram a , Swapna Chaturvedi b , Neena Bhatia
doi : 10.1016/j.dsx.2023.102741
Volume 17, Issue 3, March 2023, 102741
Type 2 diabetes (T2DM) is a chronic disease that requires continuous management and daily self-care activities. The purpose of the study was to identify the barriers and facilitators in dietary and physical activity management of T2DM by patients.
The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Leila Setayesh a , Neda Haghighat b , Niloufar Rasaei c , Mahbobe Rezaei c , Krista Casazza d , Maryam Nadery e , Ileyar yamrali c , Mohammad Zamani f, **, Omid Asbaghi
doi : 10.1016/j.dsx.2023.102729
Volume 17, Issue 3, March 2023, 102729
Emblica Officinalis (Amla) is a plant often utilized in traditional medicine due to its purported anti-inflammatory, antioxidant, hypoglycemic, and hypolipidemic properties. However, current evidence regarding its potential for preventing and treating metabolic abnormalities associated with chronic diseases remains unclear.
Risk factors associated with fasting during Ramadan among individuals with diabetes according to IDF-DAR risk score in Atbara city, Sudan: Cross-sectional hospital-based study
fian K. Noor a , Mo'min T. Alutol a , FadAllah S.A. FadAllah a , Ahmed A. Ahmed a , Sohep A. Osman a , Safaa Badi b , Ahmed Ibrahim Fathelrahman c , Musaab Ahmed d, e , Mohamed H. Ahmed
doi : 10.1016/j.dsx.2023.102743
Volume 17, Issue 3, March 2023, 102743
Ramadan is a holy month for Muslims. The aim of this study was to assess risk associated with Ramadan fasting among Sudanese individuals with diabetes (high, moderate, and low risk) according to International Diabetes Federation in collaboration with Diabetes and Ramadan International alliance (IDF-DAR) Practical Guidelines 2021 risk score.
Dose-response effects of periodic physical activity breaks on the chronic inflammatory risk associated with sedentary behavior in high- and upper-middle income countries: A systematic review and meta-analysis
Azarudheen Sahabudhee a , Chythra R. Rao b , Baskaran Chandrasekaran a, c, *, Scott J. Pedersen
doi : 10.1016/j.dsx.2023.102730
Volume 17, Issue 3, March 2023, 102730
Though moderate-vigorous physical activity (MVPA) is speculated to mitigate the inflammatory risk associated with sedentary behavior, only a fraction of the global population meets the recommended weekly dose of MVPA.
Artificial intelligence and body composition
Prasanna Santhanam a, *, Tanmay Nath b , Cheng Peng c , Harrison Bai d , Helen Zhang e , Rexford S. Ahima a , Rama Chellappa
doi : 10.1016/j.dsx.2023.102732
Volume 17, Issue 3, March 2023, 102732
Although obesity is associated with chronic disease, a large section of the population with high BMI does not have an increased risk of metabolic disease. Increased visceral adiposity and sarcopenia are also risk factors for metabolic disease in people with normal BMI.
Efficacy and safety of luseogliflozin in improving glycaemic and non-glycaemic outcomes in type-2 diabetes: A meta-analysis
Deep Dutta a, *, Jyoti Kadian b , Kunal Mahajan c , Anil Dhall d , Meha Sharma
doi : 10.1016/j.dsx.2023.102742
Volume 17, Issue 3, March 2023, 102742
No meta-analysis is available analysing the role of luseogliflozin in type-2 diabetes. We undertook this meta-analysis to address this knowledge-gap.
